Invivo therapeutics holdings corp. (NVIV)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS:
Current assets:
Cash and cash equivalents

9,201

6,602

8,136

9,898

13,203

16,660

19,707

22,320

11,614

12,910

16,434

14,322

14,440

21,464

37,665

41,629

45,767

14,920

22,146

25,114

24,516

13,459

17,634

20,850

9,846

13,980

18,333

22,232

10,300

12,825

15,549

18,036

19,605

4,363

3,686

4,963

8,964

Restricted cash

4

4

4

4

4

4

4

12

378

361

361

361

361

361

361

361

361

361

361

361

361

422

371

371

371

602

601

601

601

601

634

659

862

547

155

105

-

Marketable securities

-

-

-

-

-

-

-

-

-

-

734

7,525

11,649

11,577

-

-

-

5,274

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

767

177

386

1,007

1,118

461

637

1,235

1,151

535

475

657

940

451

413

682

617

184

268

397

543

1,072

342

-

-

20

-

-

-

143

-

-

-

104

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

378

445

-

117

220

206

-

126

462

276

-

119

241

81

Total current assets

9,972

6,783

8,526

10,909

14,325

17,125

20,348

23,567

13,143

13,806

18,004

22,865

27,390

33,853

38,439

42,672

46,745

20,739

22,775

25,872

25,420

14,953

18,347

21,599

10,662

14,602

19,052

23,054

11,109

13,570

16,310

19,159

20,744

5,015

3,961

5,310

9,045

Long-term marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

751

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property, equipment and leasehold improvements, net

66

73

70

79

89

100

112

125

72

157

190

305

395

510

630

736

846

938

1,093

1,261

1,431

1,605

1,797

1,973

2,182

2,337

2,430

2,593

2,559

2,311

2,024

684

523

520

520

525

280

Restricted cash - non current

110

110

110

110

110

110

90

90

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease right-of-use assets

1,142

1,211

1,278

1,345

1,410

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid clinical trial expenses

1,122

1,122

1,130

-

-

996

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

22

26

30

1,165

1,037

46

926

77

76

82

402

409

415

421

411

102

108

115

119

124

130

135

141

146

152

157

162

168

173

179

153

157

161

166

121

135

53

Total assets

12,434

9,325

11,144

13,608

16,971

18,377

21,476

23,859

13,291

14,045

18,596

23,579

28,951

34,784

39,480

43,510

47,699

21,792

23,987

27,257

26,981

16,693

20,285

23,718

12,996

17,096

21,646

25,816

13,842

16,061

18,488

20,001

21,429

5,702

4,604

5,971

9,379

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT):
Current liabilities:
Accounts payable

988

942

821

785

988

815

1,279

914

1,228

988

1,270

878

1,038

1,011

556

559

438

521

797

953

793

569

711

592

704

899

707

874

1,082

1,152

1,141

576

535

567

553

223

336

Loan payable, current portion

-

-

-

-

-

100

216

330

459

452

444

437

430

423

-

-

-

395

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

302

294

286

279

208

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan payable, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

416

409

403

-

389

259

320

320

-

-

-

-

-

-

-

-

106

106

50

50

41

-

-

Note payable, current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

37

55

74

74

112

-

-

-

-

-

-

-

-

-

-

Capital lease payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

11

19

27

32

37

34

31

30

32

30

-

Derivative warrant liability

-

-

-

-

-

-

-

21,469

2

4

41

519

1,073

1,314

2,695

2,359

2,954

1,907

2,451

7,722

12,644

7,224

2,716

5,721

-

0

0

0

24,557

14,584

10,800

23,527

29,000

35,473

4,087

9,362

10,647

Deferred rent, current portion

-

-

-

-

-

-

-

-

30

30

30

154

147

141

134

128

122

115

-

-

-

114

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

581

1,427

1,020

842

893

1,290

1,443

2,996

2,386

1,638

1,784

1,893

1,421

1,959

1,704

1,169

871

374

1,908

1,409

1,364

539

1,351

1,415

1,236

1,292

1,263

663

709

1,021

761

289

170

618

359

226

247

Total current liabilities

1,871

2,663

2,127

1,906

2,089

2,205

2,938

25,709

4,105

3,112

3,569

3,881

4,109

4,848

5,505

4,624

4,788

3,312

5,545

10,343

15,121

8,784

4,815

7,783

2,014

2,268

2,094

1,557

26,377

16,791

12,848

24,535

29,788

36,740

5,074

9,843

11,231

Loan payable, net of current portion

-

-

-

-

-

-

-

-

283

400

516

630

742

852

-

-

-

1,275

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan payable, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

960

1,067

1,171

-

1,376

1,600

1,600

1,600

1,920

1,920

1,920

1,920

1,920

1,920

1,800

1,578

139

171

71

83

76

-

-

Deferred rent, net of current portion

-

-

-

-

-

-

-

-

522

367

208

54

95

135

175

208

242

276

-

-

-

391

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

59

59

63

63

62

61

56

59

58

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - non current

944

1,020

1,097

1,171

1,276

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

45

36

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable-less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18

36

-

-

-

-

-

-

-

-

-

-

Capital lease payable-less current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

2

11

19

27

38

43

51

-

Total liabilities

2,874

3,742

3,287

3,140

3,427

2,266

2,994

25,768

4,968

3,935

4,345

4,610

4,982

5,835

6,640

5,899

6,201

4,863

6,921

11,943

16,721

10,775

6,735

9,703

3,934

4,206

4,051

3,477

28,177

18,372

12,999

24,726

29,887

36,861

5,194

9,894

11,231

Commitments and contingencies (Note 15)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity:
Common stock, $0.00001 par value, authorized 16,666,667 shares; 2,571,553 shares issued and outstanding, including 6,886 shares of unvested restricted stock, at March 31, 2020; 550,736 shares issued and outstanding, including 6,886 shares of unvested restricted stock, at December 31, 2019

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

0

0

0

0

0

0

0

0

0

Accumulated other comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-1

-2

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

231,132

224,741

223,644

223,576

223,508

223,440

223,286

199,720

197,013

194,016

193,493

188,862

187,523

185,955

184,411

182,986

181,689

150,497

145,901

141,841

126,344

106,172

105,419

104,672

96,073

94,798

93,796

93,104

42,144

40,842

39,925

37,740

36,209

16,656

12,079

11,813

11,235

Accumulated deficit

-221,574

-219,160

-215,788

-213,109

-209,965

-207,330

-204,805

-201,630

-188,691

-183,907

-179,243

-169,893

-163,553

-157,007

-151,572

-145,376

-140,192

-133,569

-128,836

-126,528

-116,085

-100,255

-

-

-

-81,909

-

-

-

-

-

-

-

-

-

-

-

Deficit accumulated during the development stage

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

91,870

90,658

87,012

-

76,202

70,765

56,479

43,153

34,437

42,466

44,667

47,817

12,669

15,736

13,088

Total stockholders’ equity

9,560

5,583

7,857

10,468

13,544

16,111

18,482

-1,909

8,323

10,110

14,251

18,969

23,969

28,949

32,840

37,611

41,498

16,929

17,066

15,314

10,260

5,918

13,550

14,015

9,062

12,890

17,594

22,339

-14,334

-2,310

5,488

-4,725

-8,457

-31,159

-590

-3,922

-1,852

Total liabilities and stockholders’ equity

12,434

9,325

11,144

13,608

16,971

18,377

21,476

23,859

13,291

14,045

18,596

23,579

28,951

34,784

39,480

43,510

47,699

21,792

23,987

27,257

26,981

16,693

20,285

23,718

12,996

17,096

21,646

25,816

13,842

16,061

18,488

20,001

21,429

5,702

4,604

5,971

9,379